| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-02-11 | Pershing Edward CEO | Purchase | +349,400 | +1.35%26,138,070 | $0.29 | $99,998 | View SEC filing | |
| 2024-11-25 | Pershing Edward CEO | Purchase | +803,650 | +4.99%16,917,040 | $0.29 | $230,005 | View SEC filing | |
| 2023-10-19 | Pershing Edward Director | Purchase | +193,110 | +2.88%6,908,000 | $0.29 | $55,268 | View SEC filing | |
| 2022-09-20 | Rodrigues Dominic Director | Purchase | +11,416,262 | +100.00%11,416,262 | $0.29 | $3,267,334 | View SEC filing | |
| 2017-12-18 | Glass John R See Remarks | Purchase | +200,000 | +100.00%200,000 | $0.05 | $10,792 | View SEC filing | |
| 2013-09-24 | Koe Jan Director | Purchase | +250,000 | +51.41%736,300 | N/A | N/A | View SEC filing | |
| 2012-12-03 | CULPEPPER PETER R CFO, COO | Purchase | +266,666 | +32.91%1,077,041 | N/A | N/A | View SEC filing | |
| 2012-11-20 | WACHTER ERIC PHD Chief Technology Officer | Purchase | +1,333,332 | +28.21%6,059,902 | N/A | N/A | View SEC filing | |
| 2012-11-20 | CULPEPPER PETER R CFO, COO | Purchase | +266,666 | +39.39%943,708 | N/A | N/A | View SEC filing | |
| 2007-09-24 | ADAMS DONALD E 10% Owner | Mixed | +491,146 | +9.75%5,526,123 | $1.28 | $1,107,912 | View SEC filing | |
| 2007-09-24 | ADAMS DONALD E 10% Owner | Mixed | +491,146 | +9.75%5,526,123 | $1.28 | $1,107,912 | View SEC filing | |
| 2006-05-31 | ADAMS DONALD E 10% Owner | Purchase | +40,000 | +0.60%6,656,250 | $1.57 | $62,800 | View SEC filing | |
| 2005-12-12 | WACHTER ERIC PHD Vice President Pharmaceuticals | Purchase | +264,705 | +18.84%1,669,937 | $0.75 | $198,529 | View SEC filing |
1-13 of 13
